{
    "Title": "Safety and Immunogenicity of rSh28GST Antigen in Humans: Phase 1 Randomized Clinical Study of a Vaccine Candidate against Urinary Schistosomiasis",
    "URL": "https://doi.org/10.1371/journal.pntd.0001704",
    "Published": "July 3, 2012",
    "Subject_Areas": [
        "Adverse events",
        "Alumni",
        "Antibodies",
        "Bilirubin",
        "Comparators",
        "Phase I clinical investigation",
        "Vaccination and immunization",
        "Antibody response"
    ],
    "Authors": {
        "Gilles Riveau": [
            "Inserm – Université Lille 2, Institut Pasteur de Lille, Lille, France"
        ],
        "Dominique Deplanque": [
            "Inserm CIC-CRB 9301, CHRU, Lille, France",
            "Université Lille – Nord de France, Département de Pharmacologie Médicale, Faculté de Médecine, Lille, France"
        ],
        "Franck Remoué": [
            "Inserm – Université Lille 2, Institut Pasteur de Lille, Lille, France"
        ],
        "Anne-Marie Schacht": [
            "Inserm – Université Lille 2, Institut Pasteur de Lille, Lille, France"
        ],
        "Hubert Vodougnon": [
            "Inserm CIC-CRB 9301, CHRU, Lille, France"
        ],
        "Monique Capron": [
            "Inserm – Université Lille 2, Institut Pasteur de Lille, Lille, France"
        ],
        "Michel Thiry": [
            "Eurogentec, Parc Scientifique, Seraing, Belgium"
        ],
        "Joseph Martial": [
            "Eurogentec, Parc Scientifique, Seraing, Belgium"
        ],
        "Christian Libersa": [
            "Inserm CIC-CRB 9301, CHRU, Lille, France",
            "Université Lille – Nord de France, Département de Pharmacologie Médicale, Faculté de Médecine, Lille, France"
        ],
        "André Capron": [
            "Inserm – Université Lille 2, Institut Pasteur de Lille, Lille, France"
        ]
    }
}